December 7, 2021 — Xoran Technologies was recently awarded a grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to support the company’s research and development efforts for lung computed tomography (CT) imaging.
Leveraging its knowledge and experience in the field as the pioneer and medical market leader in cone beam CT, Xoran has proposed TRON—an open-bore, truly mobile CT to assist in the identification of lung disease as a part of the grant. In addition, Xoran has established collaborative partnerships with specialists in Pulmonary and Critical Care Medicine and Radiology at the University of Michigan, Ann Arbor.
Xoran’s xCAT IQ and vTRON were showcased at RSNA 2021 in Chicago.
With the xCAT IQ—an FDA 510k-cleared mobile CT system for bone and brain imaging, Xoran has shown capability in point-of-care (POC) CT solutions for the intensive care unit (ICU) and the operating room. Now with improved image quality for better neurosurgical visualization, the xCAT IQ quickly and easily rolls up to the patient table for fast scanning, providing real-time updates on patients’ condition.
Xoran’s latest addition to its mobile CT suite is the vTRON, an open bore 3D CT, released for veterinary sale in 2021. Key features of the vTRON are the large open-bore gantry and small footprint, making it easy to implement in companion animal hospitals.
Earlier, Xoran announced it received a grant focused on integrated intraoperative imaging with surgical navigation from the National Institute of Health (NIH) and the National Cancer Institute (NCI) through the Small Business Initiative Research (SBIR) project. The funds are facilitated by a matching grant from external investors, Decathlon Capital Partners.
For more information: www.xorantech.com
April 29, 2024 
